Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

PSTI Insider Trading

Pluri Inc. | Biological Products, (No Diagnostic Substances)

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Pluri Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Biological Products, (No Diagnostic Substances) sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2014-09-16 23:30 2014-09-16 Gur-Lavie Boaz Officer - Chief Financial Officer BUY $2.84 3,478 $9,878 57,978 +6.4%
2014-09-16 23:28 2014-09-16 Aberman Zami Director, Officer - CEO & Chairman BUY $2.80 15,000 $42,000 1,730,298 +0.9%
2014-09-16 23:25 2014-09-16 YANAY YAKY Officer - COO & President BUY $2.85 10,000 $28,500 1,079,616 +0.9%
2014-03-06 00:19 2014-03-04 GERMAIN MARK Director SELL $4.02 67,858 $272,789 334,350 -16.9%
2014-02-27 00:01 2014-02-24 ROSMAN NACHUM Director SELL $4.00 45,000 $180,000 222,964 -16.8%
2014-02-13 00:08 2014-02-10 ROSMAN NACHUM Director SELL $4.02 35,000 $140,840 267,964 -11.6%
2014-01-22 00:04 2014-01-16 Kwiat Moria Director SELL $4.51 12,500 $56,403 72,500 -14.7%
2014-01-22 00:02 2014-01-16 BEN-YORAM ISRAEL Director SELL $4.51 35,625 $160,736 314,806 -10.2%
2014-01-15 00:12 2014-01-10 Aberman Zami Director, Officer - CEO & Chairman SELL $4.29 69,850 $299,985 1,715,298 -3.9%
2014-01-15 00:11 2014-01-10 YANAY YAKY Officer - CFO, Executive Vice President SELL $4.29 69,850 $299,985 1,069,616 -6.1%
2014-01-15 00:09 2014-01-10 BEN-YORAM ISRAEL Director SELL $4.29 26,453 $113,547 350,431 -7.0%
2014-01-10 02:06 2014-01-08 YANAY YAKY Officer - CFO, Executive Vice President SELL $4.25 30,150 $128,138 1,139,466 -2.6%
2014-01-10 02:04 2014-01-08 Aberman Zami Director, Officer - CEO & Chairman SELL $4.25 30,150 $128,138 1,785,148 -1.7%
2014-01-10 02:02 2014-01-07 BEN-YORAM ISRAEL Director SELL $4.12 44,797 $184,689 376,884 -10.6%
2013-11-13 00:42 2013-11-08 ROSMAN NACHUM Director SELL $3.27 67,244 $219,881 252,964 -21.0%
2013-09-16 23:33 2013-09-12 BEN-YORAM ISRAEL Director SELL $3.07 52,000 $159,890 371,681 -12.3%
2013-05-21 16:35 2013-05-16 BEN-YORAM ISRAEL Director BUY $3.04 63,902 $194,205 362,610 +21.4%
2013-05-21 16:35 2013-05-16 BEN-YORAM ISRAEL Director SELL $3.03 45,429 $137,818 338,681 -11.8%
2012-08-21 23:06 2012-08-17 Aberman Zami Director, Officer - CEO & Chairman SELL $5.00 33,853 $169,265 1,315,298 -2.5%
2012-08-21 23:05 2012-08-17 YANAY YAKY Officer - Chief Financial Officer SELL $5.00 16,927 $84,635 769,616 -2.2%
2012-08-14 22:40 2012-08-10 ROSMAN NACHUM Director SELL $4.25 55,000 $233,750 235,208 -19.0%
2011-01-20 17:47 2011-01-18 Aberman Zami Director, Officer - CEO & Chairman SELL $3.20 25,000 $80,000 849,151 -2.9%
2011-01-20 17:44 2011-01-18 YANAY YAKY Officer - Chief Financial Officer SELL $3.20 15,000 $48,000 386,543 -3.7%
2011-01-13 16:32 2011-01-11 YANAY YAKY Officer - Chief Financial Officer SELL $2.60 10,000 $26,000 401,543 -2.4%
2011-01-13 16:30 2011-01-11 Aberman Zami Director, Officer - CEO & Chairman SELL $2.60 25,000 $65,000 874,151 -2.8%
2010-12-07 22:34 2010-12-07 SHORRER DORON Director BUY $1.40 7,000 $9,800 169,348 +4.3%
2009-12-29 21:45 2009-12-28 BEN-YORAM ISRAEL Director BUY $1.13 5,000 $5,650 81,200 +6.6%
2009-12-29 21:45 2009-12-28 BEN-YORAM ISRAEL Director SELL $1.13 5,000 $5,650 76,200 -6.2%
2008-07-03 22:51 2008-06-24 BEN-YORAM ISRAEL Director BUY $1.98 2,500 $4,950 2,500 +100.0%
2007-01-08 21:28 2007-01-04 MCDOWELL DAVID E Director SELL $27.82 12,000 $333,869 290,687 -4.0%
2006-12-18 17:47 2006-12-14 FLYNT RICHARD A JR Officer - SVP and Corporate Controller OPT+S $27.69 10,000 $276,891 0 0.0%
2006-12-18 21:45 2006-12-15 MCDOWELL DAVID E Director SELL $27.67 213,145 $5,898,063 302,687 -41.3%
2006-12-05 19:21 2006-12-04 MCDOWELL DAVID E Director SELL $27.57 12,000 $330,872 302,787 -3.8%
2006-11-17 01:19 2006-11-15 QUINER PAUL J Officer - SVP and General Counsel OPT+S $27.52 12,500 $344,038 1,000 0.0%
2006-11-10 01:19 2006-11-02 MCDOWELL DAVID E Director SELL $23.77 12,000 $285,203 314,787 -3.7%
2006-10-18 21:22 2006-10-16 QUINER PAUL J Officer - SVP and General Counsel OPT+S $23.74 12,500 $296,780 1,000 0.0%
2006-10-04 20:33 2006-10-03 MCDOWELL DAVID E Director SELL $22.65 12,000 $271,798 326,787 -3.5%
2006-09-18 22:54 2006-09-15 QUINER PAUL J Officer - SVP and General Counsel OPT+S $24.23 12,500 $302,835 1,000 0.0%
2006-09-06 18:10 2006-09-05 MCDOWELL DAVID E Director SELL $22.92 12,000 $275,024 338,787 -3.4%
2006-08-31 23:58 2006-08-29 VA PARTNERS LLC Director, 10% owner BUY $21.99 3,000 $65,970 6,021,644 +0.0%
2006-08-26 00:05 2006-08-23 VA PARTNERS LLC Director, 10% owner BUY $21.92 246,071 $5,393,064 6,018,644 +4.3%
2006-08-22 00:22 2006-08-17 VA PARTNERS LLC Director, 10% owner BUY $21.81 300,301 $6,549,775 5,772,573 +5.5%
2006-08-16 20:07 2006-08-15 QUINER PAUL J Officer - SVP and General Counsel OPT+S $22.17 12,500 $277,093 1,000 0.0%
2006-08-04 15:46 2006-08-02 MCDOWELL DAVID E Director SELL $23.78 12,000 $285,353 350,787 -3.3%
2006-07-18 16:51 2006-07-17 QUINER PAUL J Officer - SVP and General Counsel OPT+S $22.14 12,500 $276,803 1,000 0.0%
2006-07-06 21:48 2006-07-05 MCDOWELL DAVID E Director SELL $24.72 12,000 $296,635 362,787 -3.2%
2006-06-16 18:33 2006-06-15 QUINER PAUL J Officer - SVP and General Counsel OPT+S $24.18 12,500 $302,193 1,000 0.0%
2006-06-07 20:07 2006-06-06 FLYNT RICHARD A JR Officer - SVP and Corporate Controller OPT+S $25.50 2,000 $51,000 0 0.0%
2006-06-05 17:10 2006-06-02 FLYNT RICHARD A JR Officer - SVP and Corporate Controller OPT+S $25.50 369 $9,410 0 0.0%
2006-06-05 23:03 2006-06-02 MCDOWELL DAVID E Director SELL $25.66 12,000 $307,884 374,787 -3.1%
SHOW ENTRIES

How to Interpret $PSTI Trades

Not every insider transaction in Pluri Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PSTI shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for PSTI

Insider activity data for Pluri Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PSTI, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.